Author details

Full Name

Baoli Hu

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37540752	Multiomics analyses reveal <i>DARS1-AS1</i>/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.	Sci Adv	2023
36824969	Development of a human glioblastoma model using humanized DRAG mice for immunotherapy.		2023
36622331	Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.	Cancer Res	2023
36861832	Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models.		2023
37426447	Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.	Cancer Res Commun	2023
37166370	Tumor Niches: Perspectives for Targeted Therapies in Glioblastoma.		2023
36849558	A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.	Nat Cell Biol	2023
35340222	Noninvasive Method for Predicting the Expression of Ki67 and Prognosis in Non-Small-Cell Lung Cancer Patients: Radiomics.	Journal of Healthcare Engineering	2022
35739422	Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.	Nat Cancer	2022
35422502	Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.	Nat Cancer	2022
35546452	Polarized macrophages promote gestational beta cell growth through extracellular signal-regulated kinase 5 signalling.	Diabetes, Obesity and Metabolism	2022
36122307	Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.	Cancer Discov	2022
36700223	Pre-clinical models for evaluating glioma targeted immunotherapies.		2022
34522857	A resource of high-quality and versatile nanobodies for drug delivery.	iScience	2021
33741710	ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.	Cancer Discov	2021
34228644	Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma.	J Clin Invest	2021
33509942	Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling.	Cancer Res	2021
34025646	TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma.	Front Immunol	2021
32958778	Telomere dysfunction activates YAP1 to drive tissue inflammation.	Nat Commun	2020
32164294	Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.	Cancers (Basel)	2020
32393472	Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis.	Molecular Cancer Therapeutics	2020
31201162	Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas.	Cancer Res	2019
31810385	LINC01518 knockdown inhibits tumorigenicity by suppression of PIK3CA/Akt pathway in oesophageal squamous cell carcinoma.	Artificial Cells, Nanomedicine and Biotechnology	2019
31519988	Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes.	Sci Rep	2019
30918400	Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.	Nature	2019
31407591	Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression.	Artificial Cells, Nanomedicine and Biotechnology	2019
29316430	Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.	Cancer Cell	2018
29527580	Gene array analysis of PD-1H overexpressing monocytes reveals a pro-inflammatory profile.	Heliyon	2018
27841882	Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.	Nat Genet	2017
29020498	LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.	Cancer Biology and Therapy	2017
28956120	miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.	Cancer Chemotherapy and Pharmacology	2017
28497891	Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis.	Thoracic Cancer	2017
28697342	Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.	Cancer Cell	2017
29340084	CRISPR-Cas9 HDR system enhances AQP1 gene expression.	Oncotarget	2017
29073105	PAF promotes stemness and radioresistance of glioma stem cells.	Proc Natl Acad Sci U S A	2017
27863244	Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.	Cell	2016
26701088	Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.	Cancer Discov	2016
26153864	Corrigendum: Passenger deletions generate therapeutic vulnerabilities in cancer.	Nature	2015
25845654	Bevacizumab did not reduce the risk of anemia associated with chemotherapy: an up-to-date meta-analysis.	European Journal of Clinical Pharmacology	2015
25965571	Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.	Cancer Cell	2015
24954535	Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.	Cell	2014
23918370	From the Cover: Neutralization of terminal differentiation in gliomagenesis.	Proc Natl Acad Sci U S A	2013
22751500	STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.	Genes Dev	2012
22895339	Passenger deletions generate therapeutic vulnerabilities in cancer.	Nature	2012
21289624	SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.	Nature	2011
17875722	Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.	Cancer Research	2007
17218780	Selectively oncolytic mutant of HSV-1 lyses HeLa cells mediated by Ras/RTN3.	Cancer Biology and Therapy	2007
17592250	Immune analysis on mtHSV mediated tumor therapy in HSV-1 seropositive mice.	Cancer Biology and Therapy	2007
16905541	MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin.	Journal of Biological Chemistry	2006
16357524	Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway.	Cancer Biology and Therapy	2006